Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers

BACKGROUND: Gamma-hydroxybutyrate (GHB; or sodium oxybate) is an endogenous GHB-/gamma-aminobutyric acid (B) receptor agonist. It is approved for application in narcolepsy and has been proposed for the potential treatment of Alzheimer’s disease, Parkinson’s disease, fibromyalgia, and depression, all...

Descripción completa

Detalles Bibliográficos
Autores principales: Dornbierer, D A, Boxler, M, Voegel, C D, Stucky, B, Steuer, A E, Binz, T M, Baumgartner, M R, Baur, D M, Quednow, B B, Kraemer, T, Seifritz, E, Landolt, H P, Bosch, O G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822136/
https://www.ncbi.nlm.nih.gov/pubmed/31504554
http://dx.doi.org/10.1093/ijnp/pyz047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822136/
https://www.ncbi.nlm.nih.gov/pubmed/31504554
http://dx.doi.org/10.1093/ijnp/pyz047

Ejemplares similares